Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies Obtains FDA Clearance For Applications Of Cellvizio Confocal Laser Endomicroscopy In Neurosurgery

May 24 (Reuters) - MAUNA KEA TECHNOLOGIES SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES OBTAINS FIRST EVER FDA CLEARANCE
FOR
APPLICATIONS OF CELLVIZIO® CONFOCAL LASER ENDOMICROSCOPY IN
NEUROSURGERY

Source text for Eikon:  ID:nBwbNHTNva 
Further company coverage:  MKEA.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Mauna Kea Technologies SA

See all news